Zeria Pharmaceutical Co., Ltd. (TYO:4559)

Market Cap	96.62B
Revenue (ttm)	82.58B
Net Income (ttm)	7.53B
Shares Out	44.08M
EPS (ttm)	170.92
PE Ratio	12.82
Forward PE	9.81
Dividend	46.00 (2.11%)
Ex-Dividend Date	Mar 28, 2025

Volume	113,500
Average Volume	96,635
Open	2,216.00
Previous Close	2,206.00
Day's Range	2,166.00 - 2,220.00
52-Week Range	1,921.00 - 2,505.00
Beta	-0.11
RSI	56.67
Earnings Date	May 9, 2025

About Zeria Pharmaceutical

Zeria Pharmaceutical Co., Ltd., together with its subsidiaries, manufactures, sells, imports, and exports pharmaceuticals, non-pharmaceutical products, veterinary pharmaceuticals, agricultural chemicals, industrial chemicals, and reagents in Japan and internationally. It also provides cosmetics, health foods, alcoholic beverages, soft drinks, food additives, livestock feed, hygienic goods, medical devices, health equipment, hygiene facilities and equipment, beauty appliances, and measuring and analytical equipment. The company also offers produ...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1955
• Employees: 1,777
• Stock Exchange: Tokyo Stock Exchange
• Ticker Symbol: 4559

Financial Performance

In 2023, Zeria Pharmaceutical's revenue was 75.73 billion, an increase of 10.74% compared to the previous year's 68.38 billion. Earnings were 7.73 billion, an increase of 24.79%.